CMS Open Payments · Program Year 2024
MIMEDX Group, Inc.
MIMEDX Group, Inc. reported $3,368,456.89 across General Payments, Research, and Ownership to 12,157 physicians and teaching hospitals across 12,164 transactions.
- $3.4M Top quartile payer
- All-tracks total
- 12,164 Top 10% volume
- Transactions
- 12,157 Top 10% reach
- Recipients
- #335
- of 1,925 companies
MIMEDX Group, Inc. reported $3,368,456.89 across all CMS Open Payments tracks (General + Research + Ownership) to 12,157 physicians and teaching hospitals in Program Year 2024 - ranking #335 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $3,325,462.68, averaging $277.08 per recipient.
How MIMEDX Group, Inc.'s $3.4M all-tracks total breaks down
MIMEDX Group, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
C
72/100
Total payments
F
41/100
Transaction volume
A
98/100
Physician reach
A
100/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer mimedx-group-inc MIMEDX Group, Inc.
$3.4M · #335/1,925 · 0.0% industry · PY2024
- TOT $3.4M
- RANK #335
- SHARE 0.0%
- TXN 12,164
- RCP 12,157
- CAT 4
- GEN $3.3M
- TOP1 10.7%
- PY 2024
Volume peers
Nearest volume peer: Elekta, Inc. ($3.4M)
MIMEDX Group, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for MIMEDX Group, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For MIMEDX Group, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
1,671 transactions worth $1.6M make "Consulting Fee" the top general-payment category in the 4-category breakdown below, 49.2% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
MIMEDX Group, Inc. made 4 types of general payments. "Consulting Fee" is the largest category at $1.6M, 49.2% of General Payments.
MIMEDX Group, Inc. reports 4 general-payment categories - the top three are Consulting Fee (49.2%), Compensation for Services Other Than Consulting (34.6%), and Food and Beverage (11.9%). The remaining 1 category make up 4.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How MIMEDX Group, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $1.6M | 1,671 | 49.2% |
| Compensation for Services Other Than Consulting | $1.1M | 127 | 34.6% |
| Food and Beverage | $396.8K | 9,925 | 11.9% |
| Travel and Lodging | $144.8K | 434 | 4.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,176,022.30 (35.4%) of $3,325,462.68 in this company's General Payments records across 5,222 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for MIMEDX Group, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Cato Laurencin
$355,912.60 across 30 reported transactions
- 2
Inova Fairfax Hospital
$351,600.00 across 50 reported transactions
- 3
Phyllis I Gardner
$319,668.75 across 4 reported transactions
- 4
Megan Oltmann
$84,040.95 across 63 reported transactions
- 5
Adventhealth Orlando
$64,800.00 across 51 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
MIMEDX Group, Inc. ranks #335 of 1,925 by total payments (top 17% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,404 of 1,838 by HHI (bottom 24% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Paragon 28, Inc. : $3.4M total payments, HHI 370
- Sonio : $192.5K total payments, HHI 370
- Visioneering Technologies, Inc. : $417.3K total payments, HHI 369
- Veloxis Pharmaceuticals, Inc. : $89.2K total payments, HHI 365
- Hiossen, Inc. : $2.4M total payments, HHI 364
- Berlin Heart Inc : $40.7K total payments, HHI 364
- MIMEDX Group, Inc. (this company) : $3.3M total payments, HHI 364
- PhotoniCare Inc : $71.2K total payments, HHI 363
- Vilex LLC : $1.1M total payments, HHI 363
- 4WEB, Inc. : $141.8K total payments, HHI 362
- Sawtooth Surgical Solutions Inc : $23.1K total payments, HHI 359
- Invictus Surgical Incorporated : $23.2K total payments, HHI 358
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as MIMEDX Group, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about MIMEDX Group, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with MIMEDX Group, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Integra LifeSciences Corporation
Oyster Point Pharma, Inc.
Merit Medical Systems Inc
Biotissue Holdings Inc.
Paratek Pharmaceuticals, Inc.
Put this to use
MIMEDX Group, Inc. ranks #335 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where MIMEDX Group, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just MIMEDX Group, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.